Debra White - 22 Feb 2024 Form 4 Insider Report for Lucid Diagnostics Inc. (LUCD)

Role
Director
Signature
/s/ Michael A. Gordon, by power of attorney
Issuer symbol
LUCD
Transactions as of
22 Feb 2024
Net transactions value
$0
Form type
4
Filing time
23 Feb 2024, 16:49:01 UTC
Previous filing
02 Feb 2023
Next filing
21 Feb 2025
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction LUCD Employee stock option (right to buy) Award $0 +150,000 $0.000000 150,000 22 Feb 2024 Common stock 150,000 $1.23 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 One third of the option vests on December 31, 2024; the balance vests in eight equal quarterly installments, starting March 31, 2025.